BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38000679)

  • 1. Gastric metaplasia as a precursor of nonconventional dysplasia in inflammatory bowel disease.
    Musulen E; Gené M; Cuatrecasas M; Amat I; Veiga JA; Fernández-Aceñero MJ; Chimisana VF; Tarragona J; Jurado I; Fernández-Victoria R; Martínez-Ciarpaglini C; Alenda González C; Zac C; Fernández-Figueras MT; Esteller M
    Hum Pathol; 2024 Jan; 143():50-61. PubMed ID: 38000679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-conventional dysplasia in inflammatory bowel disease is more frequently associated with advanced neoplasia and aneuploidy than conventional dysplasia.
    Lee H; Rabinovitch PS; Mattis AN; Lauwers GY; Choi WT
    Histopathology; 2021 May; 78(6):814-830. PubMed ID: 33155325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique immunohistochemical profiles of MUC5AC, MUC6, P53, and Ki67 in gastric atypical hyperplasia and dysplasia.
    Miao L; Sun Y; Guo M; Yang H; Du X; Li J; Shen J; Wang X; Lei R
    Int J Clin Exp Pathol; 2024; 17(3):63-71. PubMed ID: 38577693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of low and high-grade dysplasia in inflammatory bowel disease: the gastroenterologists' perspective and current practice in the United Kingdom.
    Thomas T; Nair P; Dronfield MW; Mayberry JF
    Eur J Gastroenterol Hepatol; 2005 Dec; 17(12):1317-24. PubMed ID: 16292084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonconventional dysplasia in patients with inflammatory bowel disease and colorectal carcinoma: a multicenter clinicopathologic study.
    Choi WT; Yozu M; Miller GC; Shih AR; Kumarasinghe P; Misdraji J; Harpaz N; Lauwers GY
    Mod Pathol; 2020 May; 33(5):933-943. PubMed ID: 31822800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in p53, Microsatellite Stability and Lack of MUC5AC Expression as Molecular Features of Colorectal Carcinoma Associated with Inflammatory Bowel Disease.
    Gené M; Cuatrecasas M; Amat I; Veiga JA; Fernández Aceñero MJ; Fusté Chimisana V; Tarragona J; Jurado I; Fernández-Victoria R; Martínez Ciarpaglini C; Alenda González C; Zac C; Ortega de la Obra P; Fernández-Figueras MT; Esteller M; Musulen E
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysplasia-like epithelial atypia in ischemic bowel disease.
    Abraham SC; Taggart MW; Loftus EV; Wu TT
    Hum Pathol; 2014 Jul; 45(7):1348-57. PubMed ID: 24946975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: a retrospective study comparing chromoendoscopy and white-light endoscopy.
    Ten Hove JR; Mooiweer E; van der Meulen de Jong AE; Dekker E; Ponsioen CY; Siersema PD; Oldenburg B
    Endoscopy; 2017 Feb; 49(2):161-168. PubMed ID: 27951611
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypermucinous, Goblet Cell-Deficient and Crypt Cell Dysplasias in Inflammatory Bowel Disease are Often Associated with Flat/Invisible Endoscopic Appearance and Advanced Neoplasia on Follow-Up.
    Choi WT; Salomao M; Zhao L; Alpert L; Setia N; Liao X; Drage MG; Westerhoff M; Cheng J; Lauwers GY; Ko HM
    J Crohns Colitis; 2022 Jan; 16(1):98-108. PubMed ID: 34232295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Development of More-advanced Lesions in Patients With Inflammatory Bowel Diseases and Dysplasia.
    Cremer A; Demetter P; De Vos M; Rahier JF; Baert F; Moreels T; Macken E; Louis E; Ferdinande L; Fervaille C; Dedeurwaerdere F; Bletard N; Driessen A; De Hertogh G; Vermeire S; Franchimont D;
    Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1528-1536.e5. PubMed ID: 31202983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-MET immunohistochemical expression in sporadic and inflammatory bowel disease associated lesions.
    Halliday G; Porter RJ; Black CJ; Arends MJ; Din S
    World J Gastroenterol; 2022 Apr; 28(13):1338-1346. PubMed ID: 35645542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
    J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonconventional Dysplasia is Frequently Associated With Goblet Cell Deficient and Serrated Variants of Colonic Adenocarcinoma in Inflammatory Bowel Disease.
    Xiao A; Yozu M; Kővári BP; Yassan L; Liao X; Salomao M; Westerhoff M; Sejben A; Lauwers GY; Choi WT
    Am J Surg Pathol; 2024 Jun; 48(6):691-698. PubMed ID: 38546105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term Risk of Advanced Neoplasia After Colonic Low-grade Dysplasia in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study.
    De Jong ME; Van Tilburg SB; Nissen LHC; Kievit W; Nagtegaal ID; Horjus CS; Römkens TEH; Drenth JPH; Hoentjen F; Derikx LAAP
    J Crohns Colitis; 2019 Dec; 13(12):1485-1491. PubMed ID: 31175827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
    Dorer R; Odze RD
    Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA flow cytometric and interobserver study of crypt cell atypia in inflammatory bowel disease.
    Wen KW; Umetsu SE; Goldblum JR; Gill RM; Kim GE; Joseph NM; Rabinovitch PS; Kakar S; Lauwers GY; Choi WT
    Histopathology; 2019 Oct; 75(4):578-588. PubMed ID: 31111543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotensin receptor 1 overexpression in inflammatory bowel diseases and colitis-associated neoplasia.
    Gui X; Liu S; Yan Y; Gao Z
    World J Gastroenterol; 2013 Jul; 19(28):4504-10. PubMed ID: 23901225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemistry in the diagnosis of dysplasia in chronic inflammatory bowel disease colorectal polyps.
    B Brahim E; Mrabet A; Jouini R; Koubaa W; B Sidhom R; Elloumi H; Chadli A
    Arab J Gastroenterol; 2016 Sep; 17(3):121-126. PubMed ID: 27567189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revisiting the distinct histomorphologic features of inflammatory bowel disease-associated neoplastic precursor lesions in the SCENIC and post-DALM Era.
    Gui X; Iacucci M; Ghosh S; Ferraz JGP; Lee S
    Hum Pathol; 2020 Jun; 100():24-37. PubMed ID: 32387105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
    Navaneethan U; Jegadeesan R; Gutierrez NG; Venkatesh PG; Hammel JP; Shen B; Kiran RP
    J Crohns Colitis; 2013 Dec; 7(12):e684-91. PubMed ID: 23916526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.